The FDA’s take on obesity medication for children

By Dr Nicola Davies

Shortly after Robert F Kennedy Jr was sworn in as Secretary of Health and Human Services (HHS), US President Donald Trump issued an executive order establishing the Make America Healthy Again Commission.

One of its goals was to investigate the use of obesity medications in children - framing such use as a potential threat to adolescent health. Secretary Kennedy, who chairs the commission, has made it his mandate to reverse the increasing rates of childhood obesity in America, stating that spending more on quality food would solve the obesity crisis overnight.1